About this trial
This single-center, prospective, observational study evaluates the impact of perioperative sepsis on inflammatory response, coagulation abnormalities, cardiac dysfunction, and microRNA expression in adult patients undergoing major abdominal surgery. Forty patients are enrolled and classified into septic and non-septic groups according to international sepsis definitions based on SOFA score criteria. Clinical, biochemical, echocardiographic, and molecular parameters, including selected microRNAs, are assessed preoperatively and within the first 24 hours postoperatively. The study aims to characterize pathophysiological differences associated with perioperative sepsis and to explore the potential prognostic value of microRNAs as early biomarkers of postoperative sepsis.
Eligibility criteria
Qualifiers
Age ≥18 years
Undergoing major abdominal surgery (elective or emergency)
Ability to provide written informed consent
Availability of biological samples in the preoperative period and within 24 hours postoperatively
Disqualifiers
Surgical reintervention within 3 months after the index procedure
Multiple surgical procedures during the same hospitalization
Active chronic infections (HIV, active viral hepatitis, tuberculosis)
Autoimmune or systemic inflammatory diseases
Trial design
Treatments tested in this trial
- • Presepsin • C-reactive protein (CRP) • Fibrinogen • Aspartate aminotransferase (AST) • Alanine aminotransferase (ALT) • Creatinine • Urea • Creatine kinase (CK) • Creatine kinase-MB (CK-MB) • NT-pro